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1. Flavivirus Introduction
• Genus within the Flaviviridae
• Over 70 species
• Positive stranded RNA viruses
• Primarily transmitted to mammals by 
mosquitoes and ticks
• Generally cause a mild febrile illness
• Severe forms often fatal, involving either 
encephalitic or haemorrhagic pathologies.
• All contain a NS2B/NS3 two-component 
protease crucial for viral replication
2. A membrane-bound 
protease
 
• The protease is tethered to the lumenal 
side of the ER membrane in infected cells
• The transmembrane tethers are the α-
helical portions of the NS2B protein.
• NS2B forms a loop that cradles NS3 close 
to the membrane.
• Viral protein substrates are also membrane 
bound
3. The UQ construct 
•Originally developed for Dengue, a construct 
with a flexible GGGGSGGGG linker enabled 
production of soluble protein for in vitro 
studies,1 crystal structures2
• Constructs with GnSGn linkers have been 
successfully extended to multiple other 
viruses including WNV, ZIKV, MVEV,  KUN, 
TBEV,  JEV,  YFV
4. Crystal Structures
• These constructs enabled structures of 
several viral proteases to be solved
• Dengue (2fom, 2vbc, 3l6p, 3lkw, 3u1i, 3u1j, 
4m9f, 4m9i, 4m9k, 4m9m, 4m9t, 
• WNV (2fp7, 2ggv, 2ijo, 3e90,2 2yol, 5idk, 
2ggw)
• ZIKV (5lc0, 5t1v, 5gj4, 5gxj)
• These structures are of great importance 
for computer-based drug design and 
homology modelling of other flaviviral 
proteases.
5. Features and failures 
of the crystal structures
Structure 3e902
• The WNV NS2B protein encircles NS3 and 
interacts with inhibitors
• NS2B highly flexible in absence of inhibitors 
and moves away from active site
• The flexible linker usually entirely missing in 
the electron density along with N-terminus 
of NS3 and some of the NS2B C-terminus
• Critical NS2B residues involved in inhibitor 
and substrate binding often also missing.
6. Uncertiancies 
• Location of linker uncertain
• Interactions of inhibitors with linker 
uncertain
• Does the “missing” linker impede access of 
inhibitors to the active site
• Need a useful model of the entire active species
• Can we use these synthetic constructs with 
confidence?
• Or are alternate bimolecular constructs 
without linkers more biorelevant?3
7.  The New “UQ" WNV 
model
• The missing residues from the 3e90 
structure were added using Schrödinger 
Suite 2016-3/Prime and whole protein 
minimised.
• More potent (Ki=9nM) inhibitor PhAcKKR-
aldehyde added and docked with GOLD
Red=NS2B; Green=NS3; Magenta=missing NS3 N-terminus; 
Cyan=Linker, Grey Sticks=aldehyde Inhibitor
 
8. Docking and Molecular 
Dynamics
• The whole flexible region extends from the 
last β-strand of NS2B, through the linker to 
the N-terminus of NS3
• Ran 1µs Molecular dynamics using 
Schrödinger Desmond
• The flexible linker was indeed flexible, but 
did make multiple transient contacts to NS3, 
particularly between 300-400 ns
• The inhibitor was very stable throughout 
the simulation
• A number of important protein-ligand 
contacts were maintained throughout the 
simulation
9. Conclusions
• The flexible GnSGn linker does not impede 
access to the active site
• The linker doesn’t directly interact with the 
inhibitor.
• Linked constructs remain valid biochemical 
tools
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